Revive Therapeutics Ltd (RVVTF)

[ReikoBlack]

From the article...

"Trump's decision to forge ahead is predicated by a study conducted by the Mayo Clinic and the National Institutes of Health which found that plasma treatments appeared to have a small but statistically significant impact on reducing mortality in hospitalized Covid-19 patients who received the infusions within three days of the onset of symptoms, compared with those who got plasma later.

Pouring cold water on Trump's major announcement, however, Statnews notes that the decision, which Trump’s press secretary heralded ahead of time as a “major therapeutic breakthrough," likely falls far short of that description, "and could generate intense controversy inside the administration and the broader scientific community."

Reiko, thanks for the update.